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Primary cultures of fibroblasts obtained from the pap-
illary, reticular and subcutaneous layer of scleroderma 
skin were analyzed for protein synthesis by metabolic 
labeling and radioimmunoassays. Several of these cul-
tures shpwed a 10- to 20-fold increase in the production 
of total protein and collagen as well as of fibronectin and 
type III pro collagen as compared to cells from unaffected 
individuals. Most of the increases were noted in the 
reticular and subcutaneous layers. With cells from other 
patients increased synthesis was found in some of the 
explants or for only some of the products. The hetero-
geneity observed here could represent heterogeneity in 
the disease, in the cells studied or in the state of the 
disease at the time the cells were obtained. 
Different mechanisms have been proposed for the pathogen-
esis of systemic scleroderma: primary alterations in the blood 
vessels, an autoimmune process and a derangement in collagen 
metabolism [1,2]. The development of fibrosis in skin and 
various other organs is a prominent feature of scleroderma. The 
excessive deposition of connective tissue in scleroderma skin 
may involve the interstitial collagens type I and III [3,4], 
fibronectin [5,6] and perhaps also changes in basement mem-
brane components [6] since all of these substances increase in 
diseased tissue. While the underlying pathogenetic mechanism 
of the .·disease is not known, collagen metabolism is clearly 
altered. Most but not all studies [7-11] on skin fibroblasts from 
patients with scleroderma have shown increased collagen syn-
thesis compared to normal cells. Many factors may account for 
these variations, including different culture conditions [8,12-
15], number of cell passages [9], anatomical origin of the biop-
sies [8,9] and the stage of the disease in the tissue when the 
biopsy was taken [1,2,10]. Further, the changes could be limited 
to one or a few proteins or represent a derangement altering 
the synthesis of a variety of proteins including matrix and 
cellular proteins. A recent study showed no change in the ratio 
of type I and III collagen synthesized by scleroderma fibroblasts 
[10] in agreement with biochemical data which showed these 
collagens in the usual proportion in scleroderma skin [3]. 
The purpose of the present study was to culture cells from 4 
levels of normal and scleroderma skin to account for the possi-
bility that the disease may affect predominantly the cells in the 
deeper layers of the dermis and subcutaneous tissue [1,16]. The 
biosynthetic capacity of the cells from the sites was assessed in 
primary cultures using both metabolic labeling and specific 
radioimmunoassays, 
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MATERIALS AND METHODS 
Shin Biopsies 
Excision biopsies were performed under local xylocaine anesthesia 
from 6 patients with systemic scleroderma. Some of the clinical data on 
these patients is presented in Table I. No patients were on systemic 
therapy at the time the biopsies were taken. Furthermore, none of the 
patients were on systemic therapy 6 mo prior to the biopsies. Control 
cells were obtained from similar biopsies obtained from the skin of 6 
matched female volunteers. Appropriate statements of consent were 
signed by all individuals biopsied. All biopsies were obtained from the 
external aspect of the forearm. Part of the skin specimen was fixed in 
10% buffered formalin for routine histological study while the remainder 
was processed for tissue culture studies. 
Tissue Culture 
Each skin sample was sectioned with 2 scalpels at 3 different levels 
under a dissecting microscope. Four specimens about I-mm thick were 
obtained, representing the papillary layer, the reticular dermis, the 
reticular-subcutaneous tissue junction, and the subcutaneous tissue. 
Each specimen was divided into smaller pieces, placed into Falcon 
plastic tissue culture dishes (60 X 15 mm) and allowed to stand for 5-10 
min until they become attached to the floor of the dish. The skin 
explants received Ham's F 10 medium containing glutamine (Flow 
Laboratories) and supplemented with 10% fetal calf serum, 50 units/ mJ 
of penicillin, 50 Ilg/ml of streptomycin, 5 Ilg/ mJ of chlorotetracycline 
hydrochloride and 25 units/mJ of mycostatin. All explants were kept 
under 95% 0.15% CO2 and fed twice a week. After 5-9 weeks nearly 
confluent cultures of fibroblastic cells were obtained. Since cultures 
were ready for labeling at different times the initial experiments were 
done in duplicate in order to determine any variability in collagen and 
fibronectin synthesis between cultures. No differences were noted be-
tween cultures. 
Labeling of the Cultures 
Confluent cultures were preincubated prior to labeling for 24 hI' in 
Ham's F 10 medium containing penicillin (50 units/ml) and 10% fetal 
calf serum. This was fo llowed by a 24 hr incubation in Ham's F 10 
medium containing 50 Ilg/m1 of sodium ascorbate, 50 Ilg/mJ of beta-
aminopropionitriJe, 400 D/ml of penicillin and 5 J.LCi/ml of "H-proline 
but lacking calf serum. Serum was omitted from the incubation system 
in order to eliminate exogenous fibronectin and to avoid dilution of the 
labeled proline. Since both controls and scleroderma fibroblasts we.re 
treated similarly th is factor did not affect our results. Following the 
second 24 hI' incubation period, the labeled culture medium was with-
drawn, the explants were removed, and the cells were dislodged man-
ually with a rubber policeman in ice-cold 0.1% EDTA and were dis-
rupted in a Potter-Elvejhem homogenizer. The medium and the cell 
extract were dialyzed separately against 0.5% acetic acid for 4 days at 
4°C and were then combined. Aliquots were taken for protein deter-
mination by Lowry's method, and for determining protein-bound radio-
activity in a Beckman LS 250 scintillation counter. Another aliquot of 
the material was dialyzed against 0.2 M NaCI, 0.05 M Tris-HCI, pH 7.4 
and used for radioimmunoassays and DNA determinations [17). 
Analytical Methods 
Radioactive 4-hydroxyproline and proline was assayed on a Multi-
chrom amino acid analyzer after hydrolysis of the combined medium 
and cells with 6 M Hel (24 hI', 110°C) under N 2, The relative amount 
(in %) of collagen of the total proteins synthesized was calculated as 
described previously [11). Radioimmunoassays for type III pro collagen 
using antibodies against the aminopropeptide [18] and for fibronectin 
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TABLE 1. Clinical and histological data of scleroderma patients used in the study 
Case no. Age, sex Duration of disease Skin histology Clinical picture 
1 36, f 5yr Fibrosis of the papillary and reticular dermis, sub-
cutaneous tissue normal 
Acrosclerosis, Raynaud's phenomenon, skin ulcers, 
hypertension, lung involvement 
2 29, f 8 mo Fibrosis of the papillary and reticular dermis, peri-
vascular cellular infiltrates, subcutaneous tissue 
normal 
Acrosclerosis, Raynaud's phenomenon, skin ulcers, 
esophagus involvement 
3 58, m 1 yr Fibrosis of the papillary and reticular layer and 
upper subcutaneous tissue, mild perivascular cel-
lular inftltrates 
Acrosclerosis, Raynaud's phenomenon, hyperten-
sion, lung and esophagus involvement 
4 20, f 9mo Lymphocytic inftltrates in the papillary layer, fi-
brosis of the reticular dermis 
Acrosclerosis, Raynaud's phenomenon, arthralgia, 
lung and esophagus involvement 
5 22, f 
6 30, f 
11 mo 
1 yr 
Fibrosis of the reticular dermis and subcutaneous 
tissue, mild perivascular cellular inftltrates 
Fibrosis of the papillary and reticular layers and 
the upper subcutaneous tissue, perivascular cel-
lular inftltrates 
Acrosclerosis, Raynaud's phenomenon, skin ulcers, 
lung and esophagus involvement 
Acrosclerosis, Raynaud's phenomenon, skin ulcers, 
arthralgia, lung and esophagus involvement 
using guinea pig antibodies against human plasma cold-insoluble glob-
ulin [19] followed established procedures. For the latter assay we have 
choosen a particular batch of antibodies showing the least cross-reac-
tion with fibronectin present in the fetal calf serum (Fig 1). Since the 
serum did not inhibit more than 25% of the reaction over a wide range 
of concentrations the fibroblast media were adjusted in the quantitative 
assay to dilutions causing between 40-70% inhibition. The antigenic 
identity of fibroblast and human plasma fibronectin was indicated by 
a superimposable slope of both inhibition curves. Standa.rd regression 
analysis was carried out after logarithmic transformation of data to 
account for their non-Gaussian distribution. 
Determination of the Type I and III Collagen Ratio 
Medium and cell extracts were treated with ' pepsin (100 ILg/ ml; 6 hr 
at 18°C) at pH 2 and then neutralized [11]. Collagenous protein was 
precipitated by dialysis against 2.7 M NaCI, 0.05 M Tris-HCI pH 7.4 at 
4°C and collected by centrifugation (30 min 30.000 xg). The pellet was 
dissolved in 0.5% acetic acid, dialyzed against 1 M CaCh, 0.05 M Tris-
HCI pH 7.4 and after adding 10 mg of carrier type I collagen, denatured 
(30 min, 44°C) and chromatographed on a A5 m agarose column (20). 
The relative proportions of type III collagen (y component) and type I 
collagen (a chains) was estimated from the radioactive protein con-
tained in these peaks. Further analyses were carried out with slab gel 
electrophoresis [21] using fluorography [22] to visualize and densitom-
etry to quantitate the collagenous polypeptides. 
RESULTS 
Fibroblasts derived from 4 consecutive layers of the skin of 
6 patients with scleroderma and an appropriate number or 
normal controls were examined for their biosynthetic capacity 
after reaching confluency in primary cultw·es. The analyses 
included incorporation of radioactivity into total and collage-
nous protein (Table II) and immunological quantitation of 
fibronectin and type III procollagen (Table III). With the 
normal controls the amounts of label incorporated into protein 
resembled that reported earlier [8] but the variation between 
cultures was greater by a factor of 2-3 than observed with 
subcultured fibroblasts [9,10]. The data obtained with cells 
from different layers of normal skin was similar except that 
fibroblasts from the reticular layer were about two-fold more 
active than the others. Similar results were obtained using 
DNA or the amount of cell protein as the basis of comparisons. 
The scleroderma fibroblasts showed a much larger variation 
in biosynthetic activity. The most prominent differences were 
observed in cells from case 4 where a 4- to 25-fold increase in 
a.ll parameters was observed in a.ll cultures examined. A com-
parable increase was observed for case 2 but only for cells 
derived from the reticular and reticular-fat layers. Case 3 was 
mainly restricted to an increased protein synthesis by the 
reticular-fat cells while the other cultUl'es were in the normal 
range. Cells from case 5 were normal except for a 10- to 20-fold 
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FIG 1. Inhibition curves produced in a radioimmunoassay for human 
fibronectin by plasma fibronectin (x-x), scleroderma fibroblast me-
dium (0-0), and fetal calf serum (....-e) used in the cell cultures. 
increase in fibronectin synthesis. A normal or almost normal 
biosynthetic activity was observed for the fibroblasts obtained 
from 2 other patients (cases 1 and 6). 
The data on collagen synthesis were also calculated as the 
fraction (in %) of total protein synthesis [11]. In normal cells 
collagen was 3-9% of total protein. Only 8 out of 22 scleroderma 
cell cultures studied were above the normal range. We have 
also examined by agarose chromatography the ratio between 
type I and III collagens produced by different cells from a single 
patient and found no significant difference when compared to 
a normal control (Table IV). This was confIrmed by electro-
phoretic analysis. Similar data were reported earlier for the 
ratio of type I and III pro collagen in normal and scleroderma 
fibroblasts [10]. 
These data were also compared by standard regression anal-
ysis. A good correlation (Fig 2) was observed for the incorpo-
ration of radioactive 4-hydroxyproline and the levels of type III 
pro collagen antigen. This is in agreement with the lack of 
difference in the ratio between type I and III collagen. The 
variation in some of the individual studies (Fig 2) may be due 
in part to the methods since the radioimmunoassay measures 
antigenic properties of the arninopropeptide and further pro-
cessing of the peptide [18] may lower antigenicity without 
changing hydroxyproline formation. On the other hand specific 
protein-bound radioactivity may vary with the size of the 
intracellular proline pool even though no such difference was 
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TABLE II. Protein and collagen synthesis of scleroderma fibroblast s obtained from different layers of the dermis" 
Incorporation of 3H-proline radioactivity (cpm/ng DNA) 
Proline Hydl"Oxyproline 
Papillary Reticular Reticular-fat Fat Papill ary Reticular Reticular-fat Fat. 
Scleroderma case 
1 71 41 23 19 2.4 11.8 5.4 1.0 
2 67 1207 1049 101 6.9 121.2 152.2 4.8 
3 75 50 98 76 6.5 1.2 12.4 7.3 
4 199 607 222 185 22.8 157.5 32.1 53.3 
5 30 27 n.d . 25 1.5 4.0 n.d. 7.1 
6 26 25 n.d. 20 2.0 3.0 n.d. 4.1 
Normal controls 28 ± 6 75 ± 33 40 49 ± 20 1.84 ± 0.4 8.0 ± 4 2.0 3.6 ± 1.8 
(4) (4) (1) (3) (4) (4) (1) (3) 
"Individual values for scleroderma fibroblasts. Mean values (± SD) for normal controls, Number of cell cul tures analyzed are given in brackets. 
n.d. = not determined or cell culture not available. 
TABLE III. Type III procollagen and fibronectin synthesis by scleroderma fibroblasts measured by radioimmuno assays" 
Radioimmuno assay analysis (ng/ ng DNA X 10 ' ) 
Fibronectin Type III procollagen 
Papillary Reticulru' Reticular-fat Fat. Papillru'y Reticular Reticular-fat Fat, 
Scleroderma case 
1 2.3 6.3 5.1 2.1 1.8 4.7 3.5 1.1 
2 2.5 12.4 39.4 2.5 4.4 10.7 34.4 3.4 
3 4.4 3.2 8.1 5.3 2.5 3.1 13.7 5.1 
4 75.2 103.5 111.5 41.4 14.7 34.0 17.1 16.4 
5 78.0 122.0 n.d. 95.5 5.0 11.0 n.d. 16.0 
6 6.1 6.8 n.d. 6.0 5.6 4.2 n.d. 7.7 
Normal controls 3.5 ± 1.9 11.6 ± 1.9 2.4 8.4 ± 6.5 1.9 ± 1 3.5 ± 2.4 0.9 2.4 ± 0.8 
(6) (5) (1) (6) (6) (5) (1) (6) 
" Individual values for scleroderma fibroblasts. Mean values (± SD) for normal controls. Number of cell cul tures analyzed are given in brackets. 
n.d. = not determined or cell cultures not available. 
TABLE IV. Ratio of collagen types produced by scleroderma (case 
No. 4) and normal shin fibroblasts" 
Cell culture 
Scleroderma 
Papillary 
Reticular 
Fat 
Normal 
Papillary 
Reticular 
Fat 
Type I/Type III ratio 
84/16 
89/11 
90/10 
88/12 
82/18 
83/17 
"Determined after 'pepsin-treatment by agarose chromatography. 
noted between normal and scleroderma cells in another study 
(10). A comparison of fibronectin antigen with either total 
protein or collagen synthesis showed a clear distinction between 
2 'sets of scleroderma cells. Cases 1,2,3 and 6 resembled the 
normal pattern as expressed for example by similar levels of 
fibronectin and type III pro collagen antigen (Table III). Two 
other patients (cases 4 and 5) showed in all cell cultures studied 
an increased production of fibronectin. 
Histological examination of the various patients (Table I) 
revealed a different degree of fibrosis in the various layers of 
the skin specimens and in most of them also perivascular and 
perifollicular lymphocytic infiltrates. There was no apparent 
correlation between biosynthelic capacity of primary cell cul-
tures, the histological pattern and activity and duration of the 
disease. However, establishing such relationship will certainly 
require studies on larger groups of patients and more extensive 
histology including immunofluorescence analysis (6). 
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FIG 2. Correlation between radioactive 4-hydroxyproline and type 
III procollagen measured by radioimmunoassay in cell cultures from 
scleroderma skin. The cells were obtained from either the papillary 
(x), reticular (0), subcutaneous (e) or reticular-subcutaneous (0) layer 
of the dermis. r = correlation coefficient. Data is expressed as the 
natural logarithm (\n). 
DISCUSSION 
Our studies show that fibroblasts from different layers of the 
skin differ in synthetic activity. Papillary fibroblasts proliferate 
more rapidly than reticular cells [23] while the latter show 
higher synthetic activities. Such studies suggest that the areas 
give rise to different fibroblasts . However, the ratio of type I 
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and III collagens made by these cells was similar which agrees 
with previous chemical analyses made on sections of skin [24]. 
Immunofluorescent studies showed stronger staining for type 
III collagen in upper levels of the dermis [4,25] but tllis probably 
reflects ease of reaction rather than amount. 
Cells obtained from 2 of the patients with scleroderma 
showed high levels of protein synthesis particularly type III 
pro collagen and fibronectin. Cells from other patients showed 
changes in the synthesis of some of the proteins measUTed or 
were in the normal range. These findings suggest that the cells 
from the patients are heterogenous and can show either a 
general hyperreactivity or a more limited response. Previous 
studies [7-11] using secondary cultUTes or later passages of 
scleroderma cells also demonstrated some variation in the 
amount of collagen produced which may reflect heterogeneity 
of the disease or differences in clinical activity [10]. 
It is not unexpected that fibronectin synthesis as well as 
collagen synthesis is increased in some of the scleroderma cells. 
Fibronectin is a matrix protein produced in quantities by fibro-
blasts and links the fibroblasts to their collagen matrix [26,27]. 
Immunofluorescent studies indicated that fibronectin is in-
creased in scleroderma skin [5,6] and fibrotic liver [28]. Fibro-
nectin and collagen are co distributed in tissues and cell cultures 
[29] and their synthesis may be coordinately regulated. Devia-
tion may occur in scleroderma (case 5) and resemble the revival 
of embryonic synthesis patterns [30]. 
The variability between cells obtained from different skin 
layers of some scleroderma patients is compatible with the 
assumption that the fibrotic process is initiated in the deeper 
dermal layer [16]. It is possible that subpopulations of fibro-
blasts are activated [1,8,9] and maintain these characteristics 
for many generations [9]. Sinlilar differences in proliferative 
and synthetic capacity were, however, also noted for cells 
obtained from different layers of normal skin [9,23]. It is also 
possible that the particular featUTe described here for sclero-
derma cells is due to a special behavioUT in primary cultUTe and 
may be lost upon prolonged propagation. This possibility is 
cUTrently under investigation. 
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